Use of Povetacicept in Treatment of IgA Nephropathy

Drs Jonathan Barratt and Brad Rovin comment on clinical trial data regarding the use of povetacicept for the treatment of IgAN.

Related Keywords

United States ,American ,Brad Rovin ,Jonathan Barratt ,American Society Of Nephrology ,American Society ,Povetacicept ,Wigan ,Nephropathy ,Proteinuria ,Complement Inhibition ,B Cell Modulation ,Blys April ,